{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:52:01Z","timestamp":1649188321457},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Pharm Res"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1007\/bf02976615","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T03:36:58Z","timestamp":1225337818000},"page":"541-545","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-lnduced hepatic failure"],"prefix":"10.1007","volume":"25","author":[{"given":"Jun Shik","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Pil","family":"Burm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02976615_CR1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0002-9343(78)90456-4","volume":"64","author":"F. Alhenz-Gelas","year":"1978","unstructured":"Alhenz-Gelas, F., Plouin, P. F., Ducrocq, M. B., Corvol, P. E. and Menard, J., Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker acebutolol and diuretics in essential hypertension.Am. J. Med., 64, 1005\u20131012 (1978).","journal-title":"Am. J. Med."},{"key":"BF02976615_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/030006057900700307","volume":"7","author":"P. G. Baker","year":"1979","unstructured":"Baker, P. G. and Goulton, J. A., Multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice.J. Int. Med. Res., 7, 201\u2013214 (1979).","journal-title":"J. Int. Med. Res."},{"key":"BF02976615_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(82)90176-5","volume":"80","author":"J. Basil","year":"1982","unstructured":"Basil, J. and Jordan, R., Pharmacological properties of diacetolol, a major metabolite of acebutolol.Eur. J. Pharmacol., 80, 47\u201356 (1982).","journal-title":"Eur. J. Pharmacol."},{"key":"BF02976615_CR4","first-page":"28","volume":"8","author":"U. Borchard","year":"1990","unstructured":"Borchard, U., Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and renal clearance.Clin. Physio.l Biochem., 8, 28\u201334 (1990).","journal-title":"Clin. Physio.l Biochem."},{"key":"BF02976615_CR5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2125.1977.tb00802.x","volume":"4","author":"R. A. Branch","year":"1987","unstructured":"Branch, R. A., Kornhauser, D. M., Shand, D. G., Wilkinson, G. R. and Wood, A. J., Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis.J. Clin. Pharmacol. 4, 630\u2013637 (1987).","journal-title":"J. Clin. Pharmacol."},{"key":"BF02976615_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0378-4347(00)80496-X","volume":"230","author":"J. N. Buskin","year":"1982","unstructured":"Buskin, J. N., Upton, R. A., Jones, R. and Williams, R. L., High performance liquid chromatography assay of acebutolol and its metabolites in plasma and urine.J. Chromatogr., 230, 438\u2013442 (1982).","journal-title":"J. Chromatogr."},{"key":"BF02976615_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.1979.tb00896.x","volume":"3","author":"C. M. Castleden","year":"1979","unstructured":"Castleden, C. M. and George, C. F., The effect of ageing on the hepatic clearance of propranolol.Br. J. Clin. Pharmacol., 3, 49\u201354 (1979).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF02976615_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00562806","volume":"19","author":"B. Flouvat","year":"1981","unstructured":"Flouvat, B., Roux, A. and Chau, N. P., Pharmacokinetics and bioavailability of diacetolol, the main matabolite of acebutolol.Eur. J. Clin. Pharmacol., 19, 287\u2013292 (1981).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF02976615_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.2042-7158.1981.tb13811.x","volume":"33","author":"R. Gabriel","year":"1981","unstructured":"Gabriel, R., Kaye, C. M. and Sankey, M. G., Preliminary observations on the excretion of acebutolol and its acetyl matabolite in the urine and feces of man.J. Pharm. Pharmacol., 33, 386\u2013387 (1981).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF02976615_CR10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.2042-7158.1979.tb13613.x","volume":"31","author":"C. F. George","year":"1979","unstructured":"George, C. F. and Gruchy, B. S., Elimination of drugs by active intestinal transport.J. Pharm. Pharmacol., 31, 643\u2013644 (1979).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF02976615_CR11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/bdd.2510020202","volume":"2","author":"A. A. Gulaid","year":"1981","unstructured":"Gulaid, A. A., James, I. M. and Kaye, C. M., The Pharmacokinetics of acebutolol in man, following the oral administration of acebutolol as a single dose and during and after repeated oral dosing.Biopharm. Drug Dispos., 2, 103\u2013114 (1981).","journal-title":"Biopharm. Drug Dispos."},{"key":"BF02976615_CR12","first-page":"1048","volume":"14","author":"M. Homeida","year":"1988","unstructured":"Homeida, M., Jackson, L. and Roberts, C. J., Decreased first-pass metabolism of labetalol in chronic liver disease.Br. Med. J., 14, 1048\u20131050 (1988).","journal-title":"Br. Med. J."},{"key":"BF02976615_CR13","first-page":"513","volume":"26","author":"P. Lejeune","year":"1988","unstructured":"Lejeune, P., Desager, J. P., Meunier, H. and Harvengt, C., Kinetics of a single dose combination of acebutolol in patients with chronic liver disease. Intern.J. Clin. Pharm. Ther. Toxicol., 26, 513\u2013516 (1988).","journal-title":"J. Clin. Pharm. Ther. Toxicol."},{"key":"BF02976615_CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2125.1978.tb00863.x","volume":"6","author":"M. A. Martin","year":"1978","unstructured":"Martin, M. A., Phillips, C. A. and Smith, A. J., Acebutolol in hypertension a double blind trial against placebo.Br. J. Clin. Pharmcol., 6, 351\u2013356 (1978).","journal-title":"Br. J. Clin. Pharmcol."},{"key":"BF02976615_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cpt19782415","volume":"24","author":"A. J. Mclean","year":"1978","unstructured":"Mclean, A. J., Mcnamara, R. J., Souich, P. D., Gibaldi, M. and Lalka, D., Food, splanchnic blood flow and bioavailability of drugs subject to first pass metabolism.Clin. Pharmacol. Ther., 24, 5\u201310 (1978).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02976615_CR16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003088-198106050-00004","volume":"6","author":"C. G. Regardh","year":"1981","unstructured":"Regardh, C. G., Jordo, L., Ervik, M., Lundborg, P., Olsson, R. and Ronn, O., Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.Clin. Pharmacokinet., 6, 375\u2013388 (1981).","journal-title":"Clin. Pharmacokinet."},{"key":"BF02976615_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2125.1980.tb05837.x","volume":"9","author":"A. Roux","year":"1980","unstructured":"Roux, A., Flouvat, B., Chau, N. P., Letac, B. and Lucsko, B., Pharmacokinetics of acebutolol after intravenous bolus administration.Br. J. Clin. Pharmacol., 9, 215\u2013217 (1980).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF02976615_CR18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","volume":"4","author":"K. Yamaoka","year":"1971","unstructured":"Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T., A pharmacokinetics analysis program for microcomputer.J. Pharm. Dyn., 4, 879\u2013883 (1971).","journal-title":"J. Pharm. Dyn."},{"key":"BF02976615_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/bdd.2510060204","volume":"6","author":"R. Zaman","year":"1985","unstructured":"Zaman, R., Jack, D. B., Wilkins, M. R. and Kendall, M. J., Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.Biopharm. Drug Disp., 6, 131\u2013137 (1985).","journal-title":"Biopharm. Drug Disp."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02976615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02976615\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02976615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T17:29:53Z","timestamp":1558459793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02976615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["BF02976615"],"URL":"https:\/\/doi.org\/10.1007\/bf02976615","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}